Literature DB >> 15854125

Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model.

S Sasaki1, Y Hozumi, S Kondo.   

Abstract

Latanoprost and isopropyl unoprostone, which are analogues of prostaglandin F2alpha (PGF2alpha), are promising drugs for the reduction of intra-ocular pressure. However, they have been reported to have side effects, including hypertrichosis and hyperpigmentation of the eyelashes and periocular skin, and occasionally poliosis. In order to investigate these effects further, PGF2alpha, latanoprost and isopropyl unoprostone were applied to the dorsal skin of 7-week-old C57BL/6 mice, and hair length was measured during the treatment. The three molecules all showed stimulatory effects on the murine hair follicles and the follicular melanocytes in both the telogen and anagen stages, and stimulated conversion from the telogen to the anagen phase. PGE2 is known to act synergistically with PGF2alpha, and hence the influence of PGE2 was also examined. PGE2 did not induce distinct telogen-to-anagen conversion, but showed moderate growth stimulatory effects on early anagen hair follicles. In addition, we observed a case of hypertrichosis and trichomegaly with an excess of melanogenesis, leading to the emergence of white hair, suggesting that poliosis can occur as a side effect of eye treatment with solutions of PGF2alpha analogues. The stimulatory effects of PGF2alpha and PGE2 on hair growth have been discussed with regard to the role of protein kinase C and mast cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854125     DOI: 10.1111/j.0906-6705.2005.00270.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  27 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.

Authors:  Luis A Garza; Yaping Liu; Zaixin Yang; Brinda Alagesan; John A Lawson; Scott M Norberg; Dorothy E Loy; Tailun Zhao; Hanz B Blatt; David C Stanton; Lee Carrasco; Gurpreet Ahluwalia; Susan M Fischer; Garret A FitzGerald; George Cotsarelis
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

3.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

Review 4.  Androgenetic Alopecia: An Update of Treatment Options.

Authors:  Yanna Kelly; Aline Blanco; Antonella Tosti
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

Review 5.  The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration.

Authors:  Chih-Chiang Chen; Maksim V Plikus; Pin-Chi Tang; Randall B Widelitz; Cheng Ming Chuong
Journal:  J Mol Biol       Date:  2015-07-18       Impact factor: 5.469

Review 6.  Does prostaglandin D2 hold the cure to male pattern baldness?

Authors:  Ashley Nieves; Luis A Garza
Journal:  Exp Dermatol       Date:  2014-04       Impact factor: 3.960

7.  Bimatoprost in the treatment of eyelash hypotrichosis.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2010-04-26

8.  Expression and Function of Group IIE Phospholipase A2 in Mouse Skin.

Authors:  Kei Yamamoto; Yoshimi Miki; Hiroyasu Sato; Yasumasa Nishito; Michael H Gelb; Yoshitaka Taketomi; Makoto Murakami
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

9.  Current treatment strategies in pediatric alopecia areata.

Authors:  Etienne Wang; Joyce Ss Lee; Mark Tang
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

10.  Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44.

Authors:  Amanda M Nelson; Dorothy E Loy; John A Lawson; Adiya S Katseff; Garret A Fitzgerald; Luis A Garza
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.